Expectation of new treatments for idiopathic interstitial pneumonias

Japanese Journal of Geriatrics

Volumn 42, Issue 1, 2005, Pages 27-30

  Azuma, Arata ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

6 minitsu walk test; Hermansky Pudlak; Infterferon gamma; IPF; Pirfenidone

Indexed keywords

GAMMA INTERFERON; IMATINIB; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERAZINE DERIVATIVE; PIRFENIDONE; PROTEIN KINASE INHIBITOR; PYRIDONE DERIVATIVE; PYRIMIDINE DERIVATIVE;

AGED; CLINICAL TRIAL; HUMAN; LUNG; LUNG FIBROSIS; MIDDLE AGED; MORTALITY; OCULAR ALBINISM; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SURVIVAL;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; HERMANSKI-PUDLAK SYNDROME; HUMANS; INTERFERON TYPE II; LUNG; MIDDLE AGED; PIPERAZINES; PROGNOSIS; PROTEIN KINASE INHIBITORS; PULMONARY FIBROSIS; PYRIDONES; PYRIMIDINES; SURVIVAL ANALYSIS;

EID: 15744376486     PISSN: 03009173     EISSN: None     Source Type: Journal    
DOI: 10.3143/geriatrics.42.27     Document Type: Article

References (4)

1. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, et al.: Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157 (1): 199-203.
2. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH, et al.: A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341:1264-1269.
3. Azuma A, Tsuboi E, Abe S, Nukiwa T, Nakata K, Nagai S, et al.: 22: A Placebo Controlled and Double Blind Phase II Clinical Study of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Japan. Am J Respir Crit Care Med 2002, Abstract of Int. Conference (Atlanta). 729.
4. Gahl WA, Brantly M, Troendle J, Avila NA, Padua A, Montalvo C, et al.: Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metab 2002; 76: 234-242.